Guoli Lin
About
In The Last Decade
Guoli Lin
22 papers receiving 175 citations
Peers
Comparison fields: 5 of 33
- Epidemiology 131
- Hepatology 131
- Molecular Biology 31
- Surgery 24
- Oncology 19
Countries citing papers authored by Guoli Lin
This map shows the geographic impact of Guoli Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoli Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoli Lin more than expected).
Fields of papers citing papers by Guoli Lin
This network shows the impact of papers produced by Guoli Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoli Lin. The network helps show where Guoli Lin may publish in the future.
Co-authorship network of co-authors of Guoli Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Guoli Lin. A scholar is included among the top collaborators of Guoli Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoli Lin. Guoli Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 15 | |
| 13 | 44 | |
| 14 | 3 | |
| 15 | 2 | |
| 16 | Comparison of the efficacy of tenofovir disoproxil fumarate and entecavir for initial treatment of patient with chronic hepatitis B in China. | 12 |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 47 | |
| 20 | [Expression of T cell factor 4 in renal cell carcinoma]. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.